Sabby Management, LLC Biond Vax Pharmaceuticals Ltd. Call Options Transaction History
Sabby Management, LLC
- $1.52 Million
- Q2 2024
Call Options
0 transactions
Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
---|
About BiondVax Pharmaceuticals Ltd.
- Ticker BVXV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 18,678,800
- Market Cap $12M
- Description
- BiondVax Pharmaceuticals Ltd., a development stage biopharmaceutical company, focuses on developing, manufacturing, and commercializing products for the prevention and treatment of infectious diseases and other illnesses in Israel. The company has licensing and collaboration agreement with Max Planck Society and University Medical Center Götting...